Long-Term Treatment of Hypertension in Man by an Orally Active Angiotensin-Converting Enzyme Inhibitor

Clinical Science
doi 10.1042/cs055293s
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Converting Enzyme Inhibition With an Orally Active Compound in Hypertensive Man

Hypertension
Internal Medicine
1979English

Haemodynamic and Humoral Effects of Oral Perindopril, an Angiotensin Converting Enzyme Inhibitor, in Man.

British Journal of Clinical Pharmacology
Pharmacology
1987English

Angiotensin Converting Enzyme (ACE) Inhibitor

Journal of Nihon University Medical Association
2014English

Effect of Herbal Mixture as Angiotensin Converting Enzyme Inhibitor in Angiotensin-Ii Dependent Hypertension

Pakistan Veterinary Journal
Veterinary
2019English

Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2

Hypertension
Internal Medicine
2012English

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

Case Reports in Critical Care
2014English

Relative Long-Term Effects of Spironolactone in Conjunction With an Angiotensin-Converting Enzyme Inhibitor on Left Ventricular Mass and Diastolic Function in Patients With Essential Hypertension.

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2002English

Angiotensin Converting Enzyme Inhibitor Induced Hyperkalaemic Paralysis

Postgraduate Medical Journal
Medicine
2001English

Oral Converting Enzyme Inhibitor in Malignant Hypertension.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy